酒精性肝病不是代谢相关性脂肪性肝病

doi:10.3969/j.issn.1672-5069.2025.01.002

实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (1): 5-8.doi: 10.3969/j.issn.1672-5069.2025.01.002

酒精性肝病不是代谢相关性脂肪性肝病

苏雅, 王炳元

028000 内蒙古自治区通辽市内蒙古民族大学附属医院消化内科(苏雅);中国医科大学附属第一医院消化内科(王炳元)

收稿日期:2024-01-20 出版日期:2025-01-10 发布日期:2025-02-07
通讯作者: 王炳元,E-mail:wangby0908@163.com
作者简介:苏雅,女,40岁,医学硕士,主治医师。主要从事慢性肝病的诊断和治疗学研究。E-mail: suyajiayou2020@126.com

Alcoholic liver disease is not metabolic associated fatty liver disease

Su Ya, Wang Bingyuan

Department of Gastroenterology, Affiliated Hospital, Inner Mongolia Nationality University, Tongliao 028000, Inner Mongolia Autonomous Region, China

Received:2024-01-20 Online:2025-01-10 Published:2025-02-07

摘要/Abstract

关键词: 酒精性肝病, 代谢相关性脂肪性肝病, 非酒精性脂肪性肝病

Key words: Alcoholic liver disease, Metabolic associated fatty liver disease, Non-alcoholic fatty liver disease

苏雅, 王炳元. 酒精性肝病不是代谢相关性脂肪性肝病[J]. 实用肝脏病杂志, 2025, 28(1): 5-8.

Su Ya, Wang Bingyuan. Alcoholic liver disease is not metabolic associated fatty liver disease[J]. Journal of Practical Hepatology, 2025, 28(1): 5-8.

[1] Devarbhavi H,Asrani SK,Arab JP,et al.Global burden of liver disease:2023 update.J Hepatol,2023,79(2):516-537.
[2] Eslam M,Sanyal AJ,George J.Toward more accurate nomenclature for fatty liver diseases.Gastroenterology,2019,157(3):590-593.
[3] Eslam M,Newsome PN,Sarin SK,et al.A new definition for metabolic dysfunction-associated fatty liver disease:An international expert consensus statement.J Hepatol,2020,73(1):202-209.
[4] Fan J,Luo S,Ye Y,et al.Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population.Nutr Metab(Lond),2021,18(1):82.
[5] Tsutsumi T,Eslam M,Kawaguchi T,et al.MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD:Generalized estimating equation approach.Hepatol Res,2021,51(11):1115-1128.
[6] Eslam M,Sanyal AJ,George J.International consensus panel.MAFLD:a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology,2020,158(7):1999-2014.
[7] Kawaguchi T,Tsutsumi T,Nakano D,et al.MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.Clin Mol Hepatol,2022,28(2):150-163.
[8] Valenti L,Pelusi S.Redefining fatty liver disease classification in 2020.Liver Int,2020,40(5):1016-1017.
[9] Eslam M,Newsome PN,Sarin SK,et al.A new definition for metabolic dysfunction-associated fatty liver disease:an international expert consensus statement.J Hepatol,2020,73(1):202-209.
[10] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.酒精性肝病防治指南(2018年更新版).实用肝脏病杂志,2018,21(2):170-176.
[11] Singal AK,Bataller R,Ahn J,et al.ACG clinical guideline:alcoholic liver disease.Am J Gastroenterol,2018,113(2):175-194.
[12] European Association for the Study of the Liver.Electronic address:easl-office@easloffice.eu;European association for the study of the liver. eassl clinical practice guidelines:management of alcohol-related liver disease.J Hepatol,2018,69(1):154-181.
[13] Fan JG,Cai XB,Li L,et al.Alcohol consumption and metabolic syndrome among Shanghai adults:a randomized multistage stratified cluster sampling investigation.World J Gastroenterol,2008,14(15):2418-2424.
[14] Heredia NI,Dong Q,Chang S,et al.Association of alcohol use and physical activity with body mass index in mexican-origin adults.J Racial Ethn Health Disparities,2022,9(3):812-819.
[15] 张鸿,袁乐媛,王炳元.酒精性肝病与代谢综合征.胃肠病学和肝病学杂志,2013,22(8):826-829.
[16] Lee CH,Lui DT,Lam KS.Non-alcoholic fatty liver disease and type 2 diabetes:an update.J Diabetes Investig,2022,13(6):930-940.
[17] Sebastian BM,Roychowdhury S,Tang H,et al.Identification of a cytochrome P4502E1/Bid/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice.J Biol Chem,2011,286(41):35989-35997.
[18] Hwang S,Gao B.How does your fat affect your liver when you drink? J Clin Invest,2019,129(6):2181-2183.
[19] Mathur M,Yeh YT,Arya RK,et al.Adipose lipolysis is important for ethanol to induce fatty liver in the National Institute on Alcohol Abuse and Alcoholism murine model of chronic and binge ethanol feeding.Hepatology, 2023,77(5):1688-1701.
[20] Wei X,Shi X,Zhong W,et al.Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice:analysis of triacylglycerols using high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling.PLoS One,2013,8(2):e55382.
[21] Vacca A,Bulfone L,Cicco S,et al.Alcohol intake and arterial hypertension: retelling of a multifaceted story.Nutrients,2023,15(4):958.
[22] Marchi KC,Muniz JJ,Tirapelli CR.Hypertension and chronic ethanol consumption: What do we know after a century of study? World JCardiol,2014,6(5):283-294.
[23] Fuchs FD,Fuchs SC.The effect of alcohol on blood pressure and hypertension.Curr Hypertens Rep,2021,23(10):42.
[24] Lechner K,McKenzie AL,Kränkel N, et al.High-risk atherosclerosis and metabolic phenotype:the roles of ectopic adiposity,atherogenic dyslipidemia,and inflammation.Metab Syndr Relat Disord,2020,18(4):176-185.
[25] Kasper P,Martin A,Lang S,et al.NAFLD and cardiovascular diseases:a clinical review.Clin Res Cardiol,2021,110(7):921-937.
[26] Puddey IB,Zilkens RR,Croft KD,et al.Alcohol and endothelial function:a brief review.Clin Exp Pharmacol Physiol,2001,28(12):1020-1024.
[27] 袁乐媛,王炳元.脂肪肝患者饮酒量与代谢因素相关性分析.胃肠病学和肝病学杂志,2015,24(4):441-443.
[28] Rocco A,Compare D,Angrisani D,et al.Alcoholic disease:liver and beyond. World J Gastroenterol,2014,20(40):14652-14659.
[29] Braet C,Hussein Agha Y,Taleb A,et al.Sulfonylurea-induced hypoglycemia in a patient with cirrhosis.Cureus,2020,12(6):e8513.
[30] Rosales C,Gillard BK,Gotto AM Jr,et al.The alcohol-high-density lipoprotein athero-protective axis.Biomolecules,2020,10(7):987.
[31] Van Tol A,Groener JE,Scheek LM,et al.Induction of net mass lipid transfer reactions in plasma by wine consumption with dinner.Eur J Clin Invest,1995,25(6):390-395.
[32] Beulens JW,Rimm EB,Ascherio A,et al.Alcohol consumption and risk for coronary heart disease among men with hypertension.Ann Intern Med,2007,146(1):10-19.
[33] De Oliveira E Silva ER,Foster D,McGee Harper M,et al.Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II.Circulation,2000,102(19):2347-2352.
[34] Åberg F,Byrne CD,Pirola CJ,et al.Alcohol consumption and metabolic syndrome:clinical and epidemiological impact on liver disease.J Hepatol, 2023,78(1):191-206.
[35] Hagström H,Thiele M,Roelstraete B,et al.Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients.Gut,2021,70(1):170-179.

酒精性肝病不是代谢相关性脂肪性肝病

Alcoholic liver disease is not metabolic associated fatty liver disease

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	孙福荣, 王炳元. 酒精性肝病患者酒精应用障碍管理[J]. 实用肝脏病杂志, 2025, 28(1): 1-4.
[2]	赵彩霞, 杨松. 粪菌移植治疗重症酒精性肝炎研究进展^*[J]. 实用肝脏病杂志, 2025, 28(1): 9-12.
[3]	颜家佳, 杨蕊旭, 范建高. 美国胃肠病学学院酒精性肝病临床实践指南简介与解读[J]. 实用肝脏病杂志, 2025, 28(1): 17-19.
[4]	马敏, 许巧云. 非酒精性脂肪性肝病患者血清Arg-1水平和ApoB/ApoA1比值变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2025, 28(1): 52-55.
[5]	郑慧慧, 王玉蓉, 宰国田. 非酒精性脂肪性肝病合并颈动脉粥样硬化斑块患者血清IL-17、IFN-γ和IL-6变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2025, 28(1): 56-59.
[6]	沈玥, 朱宁, 王海. FibroTouch检测参数诊断非酒精性脂肪性肝炎患者效能分析^*[J]. 实用肝脏病杂志, 2025, 28(1): 60-63.
[7]	贾纪会, 张译之, 林静, 兰佳庆, 陈煜, 段钟平, 张晓慧. 柚皮苷调节NAFLD小鼠脂代谢紊乱机制研究^*[J]. 实用肝脏病杂志, 2024, 27(6): 816-819.
[8]	贾双珍, 吴天威, 吴捷. microRNA-122与非酒精性脂肪性肝病研究进展^*[J]. 实用肝脏病杂志, 2024, 27(5): 646-649.
[9]	李艳敏, 张维, 胡彦彦, 齐蕾. 老年非酒精性脂肪性肝病合并2型糖尿病患者血清TyG、内脏/皮下脂肪面积比和心脏代谢指数变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2024, 27(5): 697-700.
[10]	柳雅立, 张晶. 儿童和青少年代谢相关脂肪性肝病研究进展^*[J]. 实用肝脏病杂志, 2024, 27(4): 488-491.
[11]	中华医学会肝病学分会. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)[J]. 实用肝脏病杂志, 2024, 27(4): 494-510.
[12]	李开楊, 赵琦, 黄敬, 唐云, 蔺晓源, 刘杰民, 杨梅. 中国临床试验注册中心注册的非酒精性脂肪性肝病临床试验特征分析^*[J]. 实用肝脏病杂志, 2024, 27(4): 531-534.
[13]	农晓黎, 陈菲, 詹浩洪, 罗婷, 曾碧丹. 体检人群非酒精性脂肪性肝病发病率及其相关危险因素分析^*[J]. 实用肝脏病杂志, 2024, 27(3): 353-356.
[14]	孙世磊, 刘翠翠, 李曙光, 鲁科翔. 非酒精性脂肪性肝病合并T2DM患者血清成纤维细胞生长因子-21和分泌型卷曲相关蛋白5水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2024, 27(3): 357-360.
[15]	高洋, 张静, 卢宣霖. 非酒精性脂肪性肝病患者血清IL-1RA、CTRP13和CK-18水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2024, 27(2): 185-188.